<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03193151</url>
  </required_header>
  <id_info>
    <org_study_id>ATAGC04</org_study_id>
    <nct_id>NCT03193151</nct_id>
  </id_info>
  <brief_title>Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation</brief_title>
  <acronym>INTERLIVER</acronym>
  <official_title>Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation, a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      INTERLIVER is a prospective observational study of the relationship of the molecular
      phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical
      features and outcomes. A segment of a biopsy performed as standard-of-care for indications,
      or by center protocol, will be used for gene expression study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current standard for biopsy-based diagnoses of dysfunction of liver transplants is
      histology (the Banff system), an arbitrary international empirical consensus based on lesions
      and rules, similar in principle to the kidney, heart, and lung histology systems. Recent
      data-driven approaches using molecular and conventional technologies indicate that such
      systems frequently produce incorrect diagnoses - perhaps 40-50% in abnormal kidney or heart
      transplant biopsies and even more in lung biopsies, with great potential for harm to patients
      due to inappropriate treatment.

      To address this unmet need and improve diagnostics in the area of organ transplantation, the
      Alberta Transplant Applied Genomics Centre (ATAGC, University of Alberta) has developed a new
      diagnostic system - the Molecular MicroscopeÂ® Diagnostic System (MMDx) that interprets
      biopsies in terms of their molecular phenotype, and combines the molecular and
      histopathological features of transplant biopsies, plus clinical and laboratory parameters,
      to create the first Integrated Diagnostic System. The MMDx, developed first in kidney
      transplant biopsies because phenotypes are well established, will now be adapted to liver
      transplant biopsies. The present study will develop a Reference Set of liver biopsies, adapt
      the MMDx system to assess and report molecular phenotype of liver biopsies; and validate and
      refine this system in 300 unselected prospectively collected for clinical indications and a
      standard of care biopsies from North American and European Centers. In addition to
      demonstrating the real-time feasibility and potential value of this System in patient care,
      the study will develop and optimize a transparent and user-friendly reporting format to
      communicate this information to clinicians and obtain detailed feedback to improve its
      utility.

      Thanks to increasing interest and support from participating centers, INTERLIVER has already
      processed 509 biopsies from 455 participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2017</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assign molecular scores (probability) of T cell mediated rejection, antibody mediated rejection in liver transplant biopsies, in a reference set of 100 biopsies</measure>
    <time_frame>two years</time_frame>
    <description>Based on the reference set, create molecular classifier that predicts antibody mediated and T cell mediated rejection for next 200 biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assign in real time (two working days upon biopsy receipt) molecular scores (probability) of T cell mediated rejection and antibody mediated rejection.</measure>
    <time_frame>1 year</time_frame>
    <description>The molecular phenotype of a newly acquired sample predicts the histologic and clinical features of this sample when compared to the reference set.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Liver Dysfunction</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>liver biopsy</intervention_name>
    <description>5 mm fragment of liver transplant biopsy taken for clinical indication</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biopsy extract containing RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study aims to recruit 300 biopsies from liver transplant patients for clinical
        indications and the standard of care biopsies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  biopsy for clinical indications

        Exclusion Criteria:

          -  no consent, pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip F Halloran, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Konrad S Famulski, PhD</last_name>
    <phone>1 780 492 1725</phone>
    <email>konrad@ualberta.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Polakowski, PhD</last_name>
    <phone>1 780 492 5091</phone>
    <email>polakows@ualberta.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California San Francisco, Transplant Research Unit</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Koenisberg</last_name>
      <phone>415-502-3016</phone>
      <email>Monique.Koenigsberg@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Sandy Feng, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Transplant Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilip Moonka, MD</last_name>
      <email>DMOONKA1@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Sierra Foley</last_name>
      <email>SFoley3@hfhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marwan Abouljoud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center, Vanderbilt Transplant Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roman Perri, MD</last_name>
      <phone>615-343-2735</phone>
      <email>seth.karp@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Seth J Karp, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roman Perri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asrani Sumeet, MD</last_name>
      <email>Sumeet.Asrani@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Goran Klintmalm, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amar Gupta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Transplant Surgery, VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Baldecchi</last_name>
      <phone>804-502-3895</phone>
      <email>mary.baldecchi@vcuhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Tyler Wilkinson</last_name>
      <email>Tyler.Wilkinson@vcuhealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Chandra Bhatti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Transplant Surgery, University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine I Kling, MD MPH</last_name>
      <phone>206-598-3753</phone>
      <email>cekling@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Reyes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centenary Institute of Cancer Medicine &amp; Cell Biology, Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <zip>NSW 2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geoffrey McCaughan, MD, PhD</last_name>
      <phone>61-2-9565-6125</phone>
      <email>g.mccaughan@centenary.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Tatiana Tsoutsman</last_name>
      <email>tatiana.Tsoutsman@healthnsw.gov.au</email>
    </contact_backup>
    <investigator>
      <last_name>Geoffrey McCaughan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alberta, Laboratory Medicine and Pathology</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aldo J Montano-Losa, MD PhD</last_name>
      <phone>780 248 1892</phone>
      <email>aldomontano-loza@med.ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Aldo J Montano-Losa, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vince Bain, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Nephrology, Transplantation &amp; Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego</name>
      <address>
        <city>Katowice</city>
        <zip>40-027</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grzegorz Piecha, MD</last_name>
      <phone>(+48 79 289 0054</phone>
      <email>g.piecha@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Grzegorz Piecha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Independent Public Composite Regional Hospital</name>
      <address>
        <city>Szczecin</city>
        <zip>71-455</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Myslak, MD PhD</last_name>
      <email>m.myslak@mobicom.pl</email>
    </contact>
    <investigator>
      <last_name>Marta Marta Wawrzynowicz-Syczewska, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samir Zeair, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warsaw Medical University, Jesus the Child Clinical Hospital</name>
      <address>
        <city>Warszawa</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnieszka Perkowska-Ptasinska, MD, PhD</last_name>
      <email>aggape@poczta.onet.pl</email>
    </contact>
    <contact_backup>
      <last_name>Olga Tronina</last_name>
      <email>olga.tronina@wcem.edu.pl</email>
    </contact_backup>
    <investigator>
      <last_name>Agnieszka Perkowska-Ptasinska, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marek Pacholczyk, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warsaw Medical University, Independent Public Clinical Hospital</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Zieniewicz, MD PhD</last_name>
      <email>krzysztof.zieniewicz@wum.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Zieniewicz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michal Grat, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maciej Krasnodebski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute for Liver Science, King's College London</name>
      <address>
        <city>London</city>
        <zip>SE5 9NU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Sanchez-Fueyo, Professor</last_name>
      <email>sanchez_fueyo@kcl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Alberto Sanchez-Fueyo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Madill-Thomsen K, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, GrÄt M, Jurczyk K, Klintmalm G, KrasnodÄbski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, MyÅlak M, PÄczek L, Perkowska-PtasiÅska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, WiÄcek A, Zieniewicz K, Halloran PF. The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study. Am J Transplant. 2020 Feb 23. doi: 10.1111/ajt.15828. [Epub ahead of print]</citation>
    <PMID>32090446</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 15, 2017</study_first_submitted>
  <study_first_submitted_qc>June 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2017</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alberta</investigator_affiliation>
    <investigator_full_name>Philip Halloran</investigator_full_name>
    <investigator_title>Distinguished Professor</investigator_title>
  </responsible_party>
  <keyword>Liver transplant</keyword>
  <keyword>global gene expression</keyword>
  <keyword>molecular diagnostics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

